These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15793297)

  • 1. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.
    Dong Z; Bonfil RD; Chinni S; Deng X; Trindade Filho JC; Bernardo M; Vaishampayan U; Che M; Sloane BF; Sheng S; Fridman R; Cher ML
    Am J Pathol; 2005 Apr; 166(4):1173-86. PubMed ID: 15793297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
    Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
    J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer.
    Deng X; He G; Levine A; Cao Y; Mullins C
    Int J Cancer; 2008 Jan; 122(1):209-18. PubMed ID: 17847032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases.
    Parikka V; Väänänen A; Risteli J; Salo T; Sorsa T; Väänänen HK; Lehenkari P
    Matrix Biol; 2005 Sep; 24(6):438-47. PubMed ID: 16098718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
    Upadhyay J; Shekarriz B; Nemeth JA; Dong Z; Cummings GD; Fridman R; Sakr W; Grignon DJ; Cher ML
    Clin Cancer Res; 1999 Dec; 5(12):4105-10. PubMed ID: 10632347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.
    Bonfil RD; Dong Z; Trindade Filho JC; Sabbota A; Osenkowski P; Nabha S; Yamamoto H; Chinni SR; Zhao H; Mobashery S; Vessella RL; Fridman R; Cher ML
    Am J Pathol; 2007 Jun; 170(6):2100-11. PubMed ID: 17525276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice.
    Stearns ME; Wang M
    Clin Exp Metastasis; 1998 Nov; 16(8):693-702. PubMed ID: 10211982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
    Dahi S; Lee JG; Lovett DH; Sarkar R
    J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.
    Nabha SM; Bonfil RD; Yamamoto HA; Belizi A; Wiesner C; Dong Z; Cher ML
    Clin Exp Metastasis; 2006; 23(7-8):335-44. PubMed ID: 17136575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
    Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
    BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
    Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
    Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
    Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.
    Andersen TL; del Carmen Ovejero M; Kirkegaard T; Lenhard T; Foged NT; Delaissé JM
    Bone; 2004 Nov; 35(5):1107-19. PubMed ID: 15542036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact Co-cultures.
    Ko K; Yazumi S; Yoshikawa K; Konda Y; Nakajima M; Chiba T; Takahashi R
    Int J Cancer; 2000 Jul; 87(2):165-71. PubMed ID: 10861469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes.
    Croissandeau G; Chrétien M; Mbikay M
    Biochem J; 2002 Jun; 364(Pt 3):739-46. PubMed ID: 12049638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
    Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
    Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
    Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
    Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo.
    Zhang W; Matrisian LM; Holmbeck K; Vick CC; Rosenthal EL
    BMC Cancer; 2006 Mar; 6():52. PubMed ID: 16515711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.